Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The application of the TLR7/8 (Toll Like Receptor) agonist gel (immune response helper) resiquimod will enhance the immune response to the intradermal influenza vaccine in seniors 65-75 years of age.
Epistemonikos ID: e29296162b342326b961e2ec1979eb8f368b8b39
First added on: May 11, 2024